Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress

Brain, Behavior, and Immunity

Volumn 42, Issue , 2014, Pages 81-88

  Lindqvist, Daniel ^a,b   Wolkowitz, Owen M ^a   Mellon, Synthia ^a   Yehuda, Rachel ^c   Flory, Janine D ^c   Henn Haase, Clare ^d   Bierer, Linda M ^c   Abu Amara, Duna ^d   Coy, Michelle ^a   Neylan, Thomas C ^a   Makotkine, Iouri ^c   Reus, Victor I ^a   Yan, Xiaodan ^d   Taylor, Nicole M ^e   Marmar, Charles R ^d   Dhabhar, Firdaus S ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUND UNIVERSITY   (Sweden)

^c Inpatient Psychiatry James J Peters Veterans' Administration Medical Center   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Combat; Cytokines; Depression; Early life trauma; Inflammation; Post traumatic stress disorder (PTSD)

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; BECK DEPRESSION INVENTORY; BLOOD DONOR; BLOOD SAMPLING; BODY MASS; CENTRAL NERVOUS SYSTEM FUNCTION; CHILD; CHRONIC INFLAMMATION; CLINICIAN ADMINISTERED PTSD SCALE; DEPRESSION; DSM-IV; EARLY LIFE STRESS; EDUCATIONAL STATUS; FEMALE; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; SENSITIVITY ANALYSIS; SMOKING; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; ADULT; BLOOD; COMPLICATION; INFLAMMATION; LIFE EVENT; MENTAL STRESS; METABOLISM; SOLDIER; YOUNG ADULT;

ADULT; C-REACTIVE PROTEIN; COMBAT DISORDERS; CYTOKINES; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIFE CHANGE EVENTS; MALE; MILITARY PERSONNEL; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84908621921     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.06.003     Document Type: Article

References (71)

1. Acosta S.A., Diamond D.M., Wolfe S., Tajiri N., Shinozuka K., Ishikawa H., Hernandez D.G., Sanberg P.R., Kaneko Y., Borlongan C.V. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury. PLoS ONE 2013, 8:e81585.
2. Altemus M., Cloitre M., Dhabhar F.S. Enhanced cellular immune response in women with PTSD related to childhood abuse. Am. J. Psychiatry 2003, 160:1705-1707.
3. American Psychiatric Association, 1995. Diagnostic and statistical manual of mental disorders. fourth ed. American Psychiatric Press, Washington, DC.
4. Andrews J.A., Neises K.D. Cells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central disease. J. Neurochem. 2012, 120:26-36.
5. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom. Med. 2004, 66:411-421.
6. Baker D.G., Ekhator N.N., Kasckow J.W., Hill K.K., Zoumakis E., Dashevsky B.A., Chrousos G.P., Geracioti T.D. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. NeuroImmunoModulation 2001, 9:209-217.
7. Baker D.G., Nievergelt C.M., O'Connor D.T. Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 2012, 62:663-673.
8. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
9. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Klauminzer G., Charney D.S., Keane T.M. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav Ther. 1990, 13:187-188.
10. Blom G. Statistical Estimates and Transformed Beta Variables 1958, John Wiley & Sons, New York.
11. Bonne O., Gill J.M., Luckenbaugh D.A., Collins C., Owens M.J., Alesci S., Neumeister A., Yuan P., Kinkead B., Manji H.K., Charney D.S., Vythilingam M. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. J. Clin. Psychiatry 2011, 72:1124-1128.
12. Bremner J.D., Bolus R., Mayer E.A. Psychometric properties of the Early Trauma Inventory-Self Report. J. Nerv. Ment. Dis. 2007, 195:211-218.
13. Breslau N., Chilcoat H.D., Kessler R.C., Davis G.C. Previous exposure to trauma and PTSD effects of subsequent trauma: results from the Detroit Area Survey of Trauma. Am. J. Psychiatry 1999, 156:902-907.
14. Coughlin S.S. Post-traumatic stress disorder and cardiovascular disease. Open Cardiovasc. Med. J. 2011, 5:164-170.
15. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. NeuroImmunoModulation 2009, 16:300-317.
16. Dhabhar F.S., Malarkey W.B., Neri E., McEwen B.S. Stress-induced redistribution of immune cells-from barracks to boulevards to battlefields: a tale of three hormones-Curt Richter Award winner. Psychoneuroendocrinology 2012, 37:1345-1368.
17. Eraly S.A., Nievergelt C.M., Maihofer A.X., Barkauskas D.A., Biswas N., Agorastos A., O'Connor D.T., Baker D.G. Marine Resiliency Study Team. Assessment of plasma c-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA. Psychiatry 2014, 71:423-431.
18. First M.B. Structured Clinical Interview for DSM-IV axis I disorders 1997, American Psychiatric Press, Washington, DC.
19. Frayne S.M., Chiu V.Y., Iqbal S., Berg E.A., Laungani K.J., Cronkite R.C., Pavao J., Kimerling R. Medical care needs of returning veterans with PTSD: their other burden. J. Gen. Intern. Med. 2011, 26:33-39.
20. French R.A., VanHoy R.W., Chizzonite R., Zachary J.F., Dantzer R., Parnet P., Bluthe R.M., Kelley K.W. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J. Neuroimmunol. 1999, 93:194-202.
21. Gander M.L., von Kanel R. Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur. J. Cardiovasc. Prevention. Rehabil. 2006, 13:165-172.
22. Gill J.M., Saligan L., Woods S., Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect. Psychiatr. Care 2009, 45:262-277.
23. Gill J., Luckenbaugh D., Charney D., Vythilingam M. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol. Psychiatry. 2010, 68:999-1006.
24. Gill J.M., Saligan L., Lee H., Rotolo S., Szanton Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls. J. Psychosom. Res. 2013, 74:301-306.
25. Gros D.F., Price M., Magruder K.M., Frueh B.C. Symptom overlap in posttraumatic stress disorder and major depression. Psychiatry Res. 2012, 196:267-270.
26. Guo M., Liu T., Guo J.C., Jiang X.L., Chen F., Gao Y.S. Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac. J. Trop. Med. 2012, 5:323-325.
27. Heppner P.S., Lohr J.B., Kash T.P., Jin H., Wang H., Baker D.G. Metabolic syndrome: relative risk associated with post-traumatic stress disorder (PTSD) severity and antipsychotic medication use. Psychosomatics 2012, 53:550-558.
28. Hidalgo R.B., Davidson J.R. Posttraumatic stress disorder: epidemiology and health-related considerations. J. Clin. Psychiatry 2000, 61(Suppl 7):5-13.
29. Hoge C.W., Castro C.A., Messer S.C., McGurk D., Cotting D.I., Koffman R.L. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N. Engl. J. Med. 2004, 351:13-22.
30. Hoge E.A., Brandstetter K., Moshier S., Pollack M.H., Wong K.K., Simon N.M. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress. Anxiety 2009, 26:447-455.
31. Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013, 53:52-62.
32. Kawamura N., Kim Y., Asukai N. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Am. J. Psychiatry 2001, 158:484-486.
33. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
34. Lewitus G.M., Cohen H., Schwartz M. Reducing post-traumatic anxiety by immunization. Brain Behav. Immun. 2008, 22:1108-1114.
35. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., Hansson O., Bjorkqvist M., Traskman-Bendz L., Brundin L. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 2009, 66:287-292.
36. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 1999, 45:833-839.
37. Maier S.F., Watkins L.R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 1995, 695:279-282.
38. McCanlies E.C., Araia S.K., Joseph P.N., Mnatsakanova A., Andrew M.E., Burchfiel C.M., Violanti J.M. C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine 2011, 55:74-78.
39. McEwen B.S., Stellar E. Stress and the individual. Mechanisms leading to disease. Arch. Inter. Med. 1993, 153:2093-2101.
40. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21:195-218.
41. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
42. Morris M.C., Compas B.E., Garber J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin. Psychol. Rev. 2012, 32:301-315.
43. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 1984, 5:25-44.
44. O'Donovan A., Sun B., Cole S., Rempel H., Lenoci M., Pulliam L., Neylan T. Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis. Markers 2011, 30:123-132.
45. O'Donovan A., Neylan T.C., Metzler T., Cohen B.E. Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study. Brain Behav. Immun. 2012, 26:642-649.
46. Pace T.W., Heim C.M. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav. Immun. 2011, 25:6-13.
47. Pacella M.L., Hruska B., Delahanty D.L. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J. Anxiety Disord. 2013, 27:33-46.
48. Pervanidou P., Kolaitis G., Charitaki S., Margeli A., Ferentinos S., Bakoula C., Lazaropoulou C., Papassotiriou I., Tsiantis J., Chrousos G.P. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 2007, 32:991-999.
49. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
50. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 2004, 55:745-751.
51. Sabioncello A., Kocijan-Hercigonja D., Rabatic S., Tomasic J., Jeren T., Matijevic L., Rijavec M., Dekaris D. Immune, endocrine, and psychological responses in civilians displaced by war. Psychosom. Med. 2000, 62:502-508.
52. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
53. Seal K.H., Metzler T.J., Gima K.S., Bertenthal D., Maguen S., Marmar C.R. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am. J. Public Health 2009, 99:1651-1658.
54. Slopen N., Kubzansky L.D., McLaughlin K.A., Koenen K.C. Childhood adversity and inflammatory processes in youth: a prospective study. Psychoneuroendocrinology 2013, 38:188-200.
55. Spitzer C., Barnow S., Volzke H., Wallaschofski H., John U., Freyberger H.J., Lowe B., Grabe H.J. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J. Psychiatr. Res. 2010, 44:15-21.
56. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., Valevski A., Weizman A. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol. Psychiatry 1997, 42:345-348.
57. Stein, D.J., Ipser, J.C., Seedat, S., 2006. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst. Rev., CD002795.
58. Sutherland A.G., Cameron G.A., Alexander D.A., Hutchison J.D. Proinflammatory markers in prediction of posttraumatic psychological symptoms: a prospective cohort study. Mediators Inflamm. 2008, 2008:640659.
59. Tucker P., Ruwe W.D., Masters B., Parker D.E., Hossain A., Trautman R.P., Wyatt D.B. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol. Psychiatry 2004, 56:121-128.
60. Turner J.H., Neylan T.C., Schiller N.B., Li Y., Cohen B.E. Objective evidence of myocardial ischemia in patients with posttraumatic stress disorder. Biol. Psychiatry 2013, 74:861-866.
61. van Zuiden M., Heijnen C.J., Maas M., Amarouchi K., Vermetten E., Geuze E., Kavelaars A. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: A prospective study. Psychoneuroendocrinology. 2012, 37:1822-1836.
62. Vogt D., Smith B.N., King L.A., King D.W., Knight J., Vasterling J.J. Deployment Risk and Resilience Inventory-2 (DRRI-2): an updated tool for assessing psychosocial risk and resilience factors among service members and veterans. J. Trauma Stress 2013, 26:710-717.
63. von Kanel R., Hepp U., Kraemer B., Traber R., Keel M., Mica L., Schnyder U. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 2007, 41:744-752.
64. von Kanel R., Begre S., Abbas C.C., Saner H., Gander M.L., Schmid J.P. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. NeuroImmunoModulation 2010, 17:39-46.
65. Weiss S.J. Neurobiological alterations associated with traumatic stress. Perspect. Psychiatr. Care 2007, 43:114-122.
66. Wilson C.B., McLaughlin L.D., Nair A., Ebenezer P.J., Dange R., Francis J. Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS ONE 2013, 8:e76146.
67. Wong M.L., Licinio J. Localization of interleukin 1 type I receptor mRNA in rat brain. NeuroImmunoModulation 1994, 1:110-115.
68. Wong B.W., Meredith A., Lin D., McManus B.M. The biological role of inflammation in atherosclerosis. Can. J. Cardiol. 2012, 28:631-641.
69. Yehuda R. Biology of posttraumatic stress disorder. J. Clin. Psychiatry 2001, 62(Suppl 17):41-46.
70. Yehuda R., Golier J.A., Yang R.K., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 2004, 55:1110-1116.
71. Young E.A., Breslau N. Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch. Gen. Psychiatry 2004, 61:394-401.